Tags

Type your tag names separated by a space and hit enter

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism: Cochrane systematic review

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

"Fixed Dose Subcutaneous Low Molecular Weight Heparins Versus Adjusted Dose Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433979/all/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism:_Cochrane_systematic_review. Accessed 20 July 2019.
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433979/all/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism:_Cochrane_systematic_review. Accessed July 20, 2019.
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism: Cochrane systematic review. In Cochrane Abstracts. Available from https://evidence.unboundmedicine.com/evidence/view/Cochrane/433979/all/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism:_Cochrane_systematic_review
Fixed Dose Subcutaneous Low Molecular Weight Heparins Versus Adjusted Dose Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2019 July 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433979/all/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism: Cochrane systematic review ID - 433979 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433979/all/Fixed_dose_subcutaneous_low_molecular_weight_heparins_versus_adjusted_dose_unfractionated_heparin_for_the_initial_treatment_of_venous_thromboembolism:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -